1160995-45-8 Usage
General Description
2,4-dichloro-6-nitropyrrolo[1,2-f][1,2,4]triazine is a chemical compound with the molecular formula C5HCl2N5O2. It is a yellow crystalline solid that is mainly used in the production of various pharmaceuticals and agrochemicals. 2,4-dichloro-6-nitropyrrolo[1,2-f][1,2,4]triazine is known for its high thermal stability and is often used as an intermediate in the synthesis of other organic compounds. It is also used as a reagent in chemical research and as a building block for the construction of more complex molecules. Additionally, 2,4-dichloro-6-nitropyrrolo[1,2-f][1,2,4]triazine has potential applications in the development of new materials and as a component in the synthesis of dyes and pigments. However, it is important to handle and use this compound with caution due to its potential for toxicity and environmental impact.
Check Digit Verification of cas no
The CAS Registry Mumber 1160995-45-8 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,6,0,9,9 and 5 respectively; the second part has 2 digits, 4 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 1160995-45:
(9*1)+(8*1)+(7*6)+(6*0)+(5*9)+(4*9)+(3*5)+(2*4)+(1*5)=168
168 % 10 = 8
So 1160995-45-8 is a valid CAS Registry Number.
1160995-45-8Relevant articles and documents
TGF BETA RECEPTOR ANTAGONISTS
-
, (2017/03/08)
The invention relates generally to compounds that modulate the activity of TGFβR-1 and TGFβ R-2, pharmaceutical compositions containing said compounds and methods of treating proliferative disorders and disorders of dysregulated apoptosis, such as cancer, utilizing the compounds of the invention.
Novel series of pyrrolotriazine analogs as highly potent pan-Aurora kinase inhibitors
Abraham, Sunny,Hadd, Michael J.,Tran, Lan,Vickers, Troy,Sindac, Janice,Milanov, Zdravko V.,Holladay, Mark W.,Bhagwat, Shripad S.,Hua, Helen,Ford Pulido, Julia M.,Cramer, Merryl D.,Gitnick, Dana,James, Joyce,Dao, Alan,Belli, Barbara,Armstrong, Robert C.,Treiber, Daniel K.,Liu, Gang
scheme or table, p. 5296 - 5300 (2011/10/08)
The synthesis and SAR for a novel series of pyrrolotriazines as pan-Aurora kinase inhibitors are described. Optimization of the cyclopropane carboxamide terminus of lead compound 1 resulted in analogs with high cellular activity and improved rat PK profiles. Notably, compound 17l demonstrated tumor growth inhibition in a mouse xenograft model.